跳转至内容
Merck
CN

793558

碘化钠

anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99%

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
NaI
化学文摘社编号:
分子量:
149.89
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12352302
EC Number:
231-679-3
MDL number:
Assay:
≥99%
Grade:
anhydrous
Form:
powder
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


grade

anhydrous

Quality Level

vapor density

>1 (vs air)

product line

ReagentPlus®, Redi-Dri

assay

≥99%

form

powder

quality

free-flowing

impurities

≤1.0% water

pH

6-9 (20 °C, 50 g/L)

mp

661 °C (lit.)

InChI

1S/HI.Na/h1H;/q;+1/p-1

InChI key

FVAUCKIRQBBSSJ-UHFFFAOYSA-M

General description

碘化钠是一种无机钠盐。在有机合成中可用作碘化剂,制备各种含碘化合物。可用于通过亲核取代反应将卤代烃和磺酸酯转换为烷基碘化物和芳基碘化物。此外,碘化钠还可联合氧化剂碘化有机硼烷、酚和芳基化合物。

Application

碘化钠可用作碘盐前体,通过缓慢蒸发溶剂法合成双硫脲碘化钠(bis thiourea sodium iodide)的半有机非线性光学单晶。

Legal Information

ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC


Still not finding the right product?

Explore all of our products under 碘化钠


pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Eye Irrit. 2

存储类别

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


商品

Redi-Dri™ prevents hygroscopic powders, such as inorganic salts, from absorbing moisture and forming clumps, leaving the salts free-flowing every time.


Kohei Sano et al.
Biochemical and biophysical research communications, 464(3), 820-825 (2015-07-15)
Photoacoustic (PA) imaging is an attractive imaging modality for sensitive and depth imaging of biomolecules with high resolution in vivo. The aim of this study was to evaluate the effectiveness of an anti-epidermal growth factor receptor (EGFR) monoclonal antibody (panitumumab; Pan)
Mohamed Touati et al.
Leukemia & lymphoma, 56(2), 332-341 (2014-04-29)
Finding new prognostic factors to identify patients with Hodgkin lymphoma (HL) at risk of treatment resistance or relapse remains challenging in daily practice. We evaluated the relationship between CD68 expression, interim positron emission tomography (iPET) results and outcome in 158
Marlein Miranda Cona et al.
International journal of oncology, 44(3), 819-829 (2013-12-25)
Iodine-131‑labeled monoiodohypericin (131I‑Hyp) is a necrosis avid compound used as a complementary anticancer agent. Herein, the biodistribution in rats with re-perfused partial liver infarction (RPLI) was used to estimate its human internal radiation dosimetry. Iodine-123‑labeled monoiodohypericin (123I-Hyp) as a safer



全球贸易项目编号

货号GTIN
793558-100G04061832951331
793558-1KG04061832951348
793558-500G04061832951362